Our mission is to enable access to life changing gene therapies and help bring them from idea into reality. We partner with innovators in the gene therapy community: scientists, physicians, biotech and pharma companies and patient groups. We bring expertise in gene therapy manufacturing and therapeutics development to the table, helping champion teams that are navigating the long road from the lab bench to the bedside. With a patients-first approach, we are forging new models for working together to better accelerate these transformative medicines to reach those who need them the most.
Forge is currently building the "Hearth”, a 175,000 ft custom-designed cGMP facility, dedicated to AAV viral vector manufacturing. We offer end-to-end manufacturing services to accelerate gene therapy programs from preclinical stage through clinical, and on to commercial manufacturing.
With the Hearth as our foundation, Forge is building a promising pipeline of disease-modifying AAV-based therapies to potentially help patients with rare genetic diseases. Forge is a true gene therapy development engine bringing together access to quality, in-house manufacturing, the experience of our team in gene therapy product development, and an exciting pipeline of new therapies for patients.